Glenmark gets final US FDA nod for Mupirocin ointment

Moneycontrol Bureau

Glenmark Generics Inc, the US arm of Glenmark Generics has received final abbreviated new drug approval from the US Food and Drugs Administration for its Mupirocin ointment, which is an antibacterial used to treat skin infection called impetigo. Mupirocin ointment had annual sales of USD 55 million in the year ended March 2011, and grew 9% from a year ago, the company said citing IMS sales data. Glenmark Generics, which is a subsidiary of India